KLSE:HSPLANT Statistics

Total Valuation

KLSE:HSPLANT has a market cap or net worth of MYR 1.57 billion. The enterprise value is 1.01 billion.

Market Cap	1.57B
Enterprise Value	1.01B

Important Dates

The next estimated earnings date is Friday, May 23, 2025.

Earnings Date	May 23, 2025
Ex-Dividend Date	Mar 12, 2025

Share Statistics

KLSE:HSPLANT has 799.69 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	799.69M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.06%
Owned by Institutions (%)	10.02%
Float	218.74M

Valuation Ratios

The trailing PE ratio is 7.66 and the forward PE ratio is 10.43.

PE Ratio	7.66
Forward PE	10.43
PS Ratio	2.08
PB Ratio	0.75
P/TBV Ratio	0.75
P/FCF Ratio	11.01
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 2.83, with an EV/FCF ratio of 7.07.

EV / Earnings	4.92
EV / Sales	1.34
EV / EBITDA	2.83
EV / EBIT	3.72
EV / FCF	7.07

Financial Position

The company has a current ratio of 12.89, with a Debt / Equity ratio of 0.03.

Current Ratio	12.89
Quick Ratio	10.44
Debt / Equity	0.03
Debt / EBITDA	0.18
Debt / FCF	0.45
Interest Coverage	85.58

Financial Efficiency

Return on equity (ROE) is 10.09% and return on invested capital (ROIC) is 8.09%.

Return on Equity (ROE)	10.09%
Return on Assets (ROA)	6.74%
Return on Invested Capital (ROIC)	8.09%
Return on Capital Employed (ROCE)	10.72%
Revenue Per Employee	93,518
Profits Per Employee	25,434
Employee Count	8,046
Asset Turnover	0.30
Inventory Turnover	5.34

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.52% in the last 52 weeks. The beta is 0.21, so KLSE:HSPLANT's price volatility has been lower than the market average.

Beta (5Y)	0.21
52-Week Price Change	+6.52%
50-Day Moving Average	1.95
200-Day Moving Average	1.87
Relative Strength Index (RSI)	49.32
Average Volume (20 Days)	933,510

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KLSE:HSPLANT had revenue of MYR 752.45 million and earned 204.64 million in profits. Earnings per share was 0.26.

Revenue	752.45M
Gross Profit	211.57M
Operating Income	270.94M
Pretax Income	267.78M
Net Income	204.64M
EBITDA	356.05M
EBIT	270.94M
Earnings Per Share (EPS)	0.26

Full Income Statement

Balance Sheet

The company has 624.20 million in cash and 63.65 million in debt, giving a net cash position of 560.55 million or 0.70 per share.

Cash & Cash Equivalents	624.20M
Total Debt	63.65M
Net Cash	560.55M
Net Cash Per Share	0.70
Equity (Book Value)	2.10B
Book Value Per Share	2.63
Working Capital	805.87M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 209.48 million and capital expenditures -67.09 million, giving a free cash flow of 142.39 million.

Operating Cash Flow	209.48M
Capital Expenditures	-67.09M
Free Cash Flow	142.39M
FCF Per Share	0.18

Full Cash Flow Statement

Margins

Gross margin is 28.12%, with operating and profit margins of 36.01% and 27.20%.

Gross Margin	28.12%
Operating Margin	36.01%
Pretax Margin	35.59%
Profit Margin	27.20%
EBITDA Margin	47.32%
EBIT Margin	36.01%
FCF Margin	18.92%

Dividends & Yields

This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 6.38%.

Dividend Per Share	0.13
Dividend Yield	6.38%
Dividend Growth (YoY)	83.82%
Years of Dividend Growth	n/a
Payout Ratio	26.57%
Buyback Yield	n/a
Shareholder Yield	6.38%
Earnings Yield	13.06%
FCF Yield	9.08%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KLSE:HSPLANT has an Altman Z-Score of 3.86.

Altman Z-Score	3.86
Piotroski F-Score	n/a